Company / Total Assets
Emergent BioSolutions Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.3B
FY2025
5-year range
$1.3B / $3.2B
FY2021-FY2025
Trend
-5.1%
vs FY2024
Sector context
#63 of 214
Health Care
What the data says
At $1.3B, Emergent BioSolutions Inc.'s total assets ranks #63 of 214 in the Health Care sector. Total Assets has declined for 3 consecutive years, from $3.2B in FY2022 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of -14.5%.
Declined from $1.8B to $1.3B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -25.3%
- 5-Year CAGR
- -14.5%
- 10-Year CAGR
- -
Sector benchmark
#63 of 214 in Health CareTop 29% of 214This company $1.3B Sector average $7.5B
▼
-82.3% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of -14.5%, indicating a declining trend.
- In FY2025, total assets decreased 5.1% year-over-year.
- Ranks #63 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | -5.1% |
| FY2024 | $1.4B | -23.8% |
| FY2023 | $1.8B | -42.4% |
| FY2022 | $3.2B | +7.0% |
| FY2021 | $3.0B | +2.6% |
| FY2020 | $2.9B | +23.9% |
| FY2019 | $2.3B | +4.4% |
| FY2018 | $2.2B | +108.3% |
| FY2017 | $1.1B | +10.3% |
| FY2016 | $970.1M | -6.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026